| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/25/2003 | WO2003078613A2 Serine hydroxymethyltransferase as a target for herbicides |
| 09/25/2003 | WO2003078609A1 Methods of inducing differentiation of stem cells into a specific cell lineage |
| 09/25/2003 | WO2003078608A1 Methods of inducing differentiation of stem cells into a specific cell lineage |
| 09/25/2003 | WO2003078604A2 Tobacco rattle virus vectors and related compositions and methods |
| 09/25/2003 | WO2003078600A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 09/25/2003 | WO2003078592A2 Method for the purification, production and formulation of oncolytic adenoviruses |
| 09/25/2003 | WO2003078591A2 Cell division and proliferation preferred regulatory elements and uses thereof |
| 09/25/2003 | WO2003078590A2 Early inflorescence-preferred regulatory elements and uses thereof |
| 09/25/2003 | WO2003078589A2 Method of identifying genes controlling diferentiation |
| 09/25/2003 | WO2003078580A2 Imprinting in plants to control gene expression |
| 09/25/2003 | WO2003078577A2 Cloning of cytochrome p450 genes from nicotiana |
| 09/25/2003 | WO2003078576A2 Vector for transfection of eukaryotic cells |
| 09/25/2003 | WO2003078575A2 Molecular switches and methods for making and using the same |
| 09/25/2003 | WO2003078570A2 Multiple controls for molecular genetic analyses |
| 09/25/2003 | WO2003078568A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 09/25/2003 | WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof |
| 09/25/2003 | WO2003078466A1 Novel g protein-coupled recepotrs and genes thereof |
| 09/25/2003 | WO2003078463A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 09/25/2003 | WO2003078460A1 Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer |
| 09/25/2003 | WO2003078458A2 Tap-70, a novel marker for epithelial tumors |
| 09/25/2003 | WO2003078457A1 MUTEINS OF THE C5a ANAPHYLATOXIN, NUCLEIC ACID MOLECULES ENCODING SUCH MUTEINS, AND PHARMACEUTICAL USES OF MUTEINS OF THE C5a ANAPHYLATOXIN |
| 09/25/2003 | WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 09/25/2003 | WO2003078451A2 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 09/25/2003 | WO2003078449A2 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
| 09/25/2003 | WO2003078446A2 A building block forming a c-c or a c-hetero atom bond upon reaction |
| 09/25/2003 | WO2003078445A2 A building block forming a c=c double bond upon reaction |
| 09/25/2003 | WO2003078383A1 Novel positively charged lipids and liposomes comprising the positively charged lipids |
| 09/25/2003 | WO2003078050A2 A building block forming a c-c bond upon reaction |
| 09/25/2003 | WO2003077947A1 Methods of modulating cd200 receptors |
| 09/25/2003 | WO2003077875A2 Proteins associated with growth, differentiation, and death |
| 09/25/2003 | WO2003077868A2 Synthesis of synthons for the manufacture of bioactive compounds |
| 09/25/2003 | WO2003077863A2 Method for overexpression of zwitterionic polysaccharides |
| 09/25/2003 | WO2003077859A2 Method of inducing an enhanced immune response against hiv |
| 09/25/2003 | WO2003077852A2 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β |
| 09/25/2003 | WO2003077848A2 Jagged 2 inhibitors for inducing apoptosis |
| 09/25/2003 | WO2003077844A2 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 09/25/2003 | WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/25/2003 | WO2003077653A1 Autoinducer compounds |
| 09/25/2003 | WO2003077648A2 Methods for the identification of herbicides and the modulation of plant growth |
| 09/25/2003 | WO2003077643A2 Methods for increasing the oil content in plants by reducing the content of one or more storage proteins |
| 09/25/2003 | WO2003067251A3 Device for performing cell assays |
| 09/25/2003 | WO2003060101A3 Gene delivery system and methods of use |
| 09/25/2003 | WO2003052118A3 Bgl4 beta-glucosidase and nucleic acids encoding the same |
| 09/25/2003 | WO2003050278A3 Stabilisation of double-stranded nucleic acids using proteins |
| 09/25/2003 | WO2003044197A9 Huntington’s disease gene transcriptional factors |
| 09/25/2003 | WO2003042411A3 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease |
| 09/25/2003 | WO2003042402A3 Agents that modulate immune cell activation and methods of use thereof |
| 09/25/2003 | WO2003042246A3 Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| 09/25/2003 | WO2003042245B1 Growth hormone variations in humans and their uses |
| 09/25/2003 | WO2003040368A3 Pharmaceutical compositions of marine sponge microciona prolifera |
| 09/25/2003 | WO2003040313A3 Il-21 antagonists |
| 09/25/2003 | WO2003040295A3 Ion channel |
| 09/25/2003 | WO2003038724A9 Methods and apparatus for protein sequence analysis |
| 09/25/2003 | WO2003038041A3 Il-4 mutein proteins, antibodies, compositions, methods and uses |
| 09/25/2003 | WO2003035879A3 Promoters to control cell differentiation |
| 09/25/2003 | WO2003035682A3 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications |
| 09/25/2003 | WO2003033740A3 Apparatus and method for isolating a nucleic acid |
| 09/25/2003 | WO2003033699A3 Production, detection and use of transformant cells |
| 09/25/2003 | WO2003033519A3 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 09/25/2003 | WO2003031470A3 Dna-expression construct for treatment of infections with leishmaniasis |
| 09/25/2003 | WO2003029476A3 Process for the preparation of d-pantothenic acid and/or its salts |
| 09/25/2003 | WO2003026394A3 Cathepsin g (ctsg) disruptions, compositions and methods relating thereto |
| 09/25/2003 | WO2003025181A3 Dna sequences that encode variable regions of antibodies that bind to the prion protein (prp), and prp-binding polypeptides |
| 09/25/2003 | WO2003022988A3 Adipose-derived stem cells and lattices |
| 09/25/2003 | WO2003020885A3 Identification of sortase gene |
| 09/25/2003 | WO2003016521A3 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection |
| 09/25/2003 | WO2003016343A3 USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS |
| 09/25/2003 | WO2003013537A3 Irinotecan for treatment of cancer |
| 09/25/2003 | WO2003013535A3 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 09/25/2003 | WO2003012136A3 Method to detect splice variants of the calcineurin gene |
| 09/25/2003 | WO2003012078A3 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
| 09/25/2003 | WO2003011331A3 Materials and methods relating to improved vaccination strategies |
| 09/25/2003 | WO2003008596A3 Expression cassettes for transgenically expressing selection markers |
| 09/25/2003 | WO2003008454A3 Glycoprotein vi fusion proteins |
| 09/25/2003 | WO2003006047A3 Methods for reducing immunogenicity of polypeptides |
| 09/25/2003 | WO2003004659A3 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 09/25/2003 | WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 09/25/2003 | WO2003002114A3 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 09/25/2003 | WO2003000907A3 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 09/25/2003 | WO2003000737A3 MOUSE μ LIGHT CHAIN LOCUS |
| 09/25/2003 | WO2002103043A3 Method for the specific fast detection of bacteria which is harmful to beer |
| 09/25/2003 | WO2002102824A3 Method for specific fast detection of relevant bacteria in drinking water |
| 09/25/2003 | WO2002100998A3 Method for generating diversity |
| 09/25/2003 | WO2002100884A3 Cloned mammalian polyamine oxidase |
| 09/25/2003 | WO2002100827A9 Method for increasing the survival of dopamine secreting cells |
| 09/25/2003 | WO2002097081A3 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 09/25/2003 | WO2002097059A9 Chromosome-based platforms |
| 09/25/2003 | WO2002097049A3 Compositions and methods for binding agglomeration proteins |
| 09/25/2003 | WO2002092826A3 Composition and method for treating cancer using herpes virus |
| 09/25/2003 | WO2002092635A3 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens |
| 09/25/2003 | WO2002092628A3 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof |
| 09/25/2003 | WO2002090584A3 Method for labelling and fragmenting dna |
| 09/25/2003 | WO2002088736A3 Prenatal diagnosis method on isolated foetal cell of maternal blood |
| 09/25/2003 | WO2002088370A3 Autogene nucleic acids encoding a secretable rna polymerase |
| 09/25/2003 | WO2002082086A3 Detection of methicillin-resistant staphylococcus aureus (mrsa) |
| 09/25/2003 | WO2002081705A3 Regulation of human gnat acetyltransferase-like protein |
| 09/25/2003 | WO2002080847A3 Use of tumor necrosis factor inhibitors to treat cardiovascular disease |
| 09/25/2003 | WO2002077263A3 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 09/25/2003 | WO2002074920A3 A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same |
| 09/25/2003 | WO2002074078A3 Method for embryo after impregnation of the recipient female |